Form 4: CFO William Burns Receives Significant Equity Grant

Cross Country Healthcare's CFO, William J. Burns, was granted 51,370 restricted shares of common stock following the termination of a merger agreement.

Summary

• William J. Burns, Chief Financial Officer of Cross Country Healthcare Inc. (CCRN), was granted 51,370 restricted shares of common stock on December 18, 2025.
• The shares were granted at a price of $0, indicating a compensation award rather than a purchase.
• These restricted shares will vest in three substantially equal installments on December 18, 2026, March 31, 2027, and March 31, 2028.
• The Compensation Committee of the Board of Directors approved the grant date of December 18, 2025, which was adjusted from an originally planned March 31, 2025.
• This adjustment followed the termination of a merger agreement with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc. on December 3, 2025.
• After this transaction, Mr. Burns beneficially owns a total of 293,878 shares of common stock.

Sentiment

Score: 6

Explanation: The filing reflects a standard executive compensation event, with a slight positive tilt due to executive retention and alignment, but tempered by the underlying context of a terminated merger agreement, which could be viewed neutrally to slightly negatively depending on the reasons for termination.

Positives

• The grant of restricted shares to the CFO aligns his interests with long-term shareholder value and incentivizes sustained performance.
• A significant equity award of 51,370 shares serves as a strong retention incentive for a key executive, promoting leadership stability.
• The adjusted vesting schedule aims to align with existing equity awards, promoting consistency and predictability in the company's compensation structure.

Negatives

• The issuance of new shares, even restricted, can lead to minor dilution for existing shareholders upon vesting.
• The grant's timing, following the termination of a merger agreement, could indicate a missed strategic opportunity or challenges in previous corporate actions, though the filing does not elaborate on the reasons for termination.

Risks

• The termination of the merger agreement with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc. on December 3, 2025, could signal underlying business or strategic challenges that may impact future company performance.
• Future stock price volatility could impact the ultimate value of the restricted shares for the executive and the company's overall compensation expense.

Future Outlook

The grant of long-term equity incentives to the CFO suggests a commitment to executive retention and performance alignment following a significant corporate event (merger termination). The staggered vesting schedule indicates a multi-year horizon for executive incentives, implying a focus on sustained long-term value creation.

Management Comments

• The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.
• After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

Industry Context

Executive compensation, particularly through equity grants like restricted stock, is a standard practice in the healthcare staffing and services industry to attract, retain, and motivate key leadership. The adjustment of the grant date due to a terminated merger agreement highlights the dynamic nature of corporate strategy and its direct impact on executive incentive structures, a common occurrence in M&A-active sectors. This practice helps ensure that executive interests remain aligned with the company's strategic direction, even amidst significant corporate events.

Comparison to Industry Standards

• The use of Restricted Stock Awards (RSAs) with a multi-year vesting schedule is a common practice for executive compensation across various industries, including healthcare staffing, aligning executive interests with long-term shareholder value.
• The grant size of 51,370 shares for a CFO is substantial and competitive, comparable to equity grants seen in similar-sized public companies within the healthcare services sector, such as AMN Healthcare Services (AMN) or HealthEquity (HQY), which frequently use equity to incentivize top management.
• The adjustment of the grant date due to a significant corporate event like a merger termination is a standard response by compensation committees to ensure executive incentives remain relevant and effective in a changed strategic landscape.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential minor dilution upon vesting; improved executive retention and alignment of interests with long-term company performance.
• Employees: May signal stability in leadership following a significant corporate event, potentially boosting morale and confidence.
• Management: The CFO receives a significant long-term incentive, reinforcing commitment to the company and its strategic objectives.

Next Steps

• The restricted shares will vest in three installments on December 18, 2026, March 31, 2027, and March 31, 2028, at which point they will become fully owned by the CFO.

Key Dates

Recommendation

This Form 4 filing details a routine executive equity grant, albeit with a timing adjustment due to a terminated merger. While the grant aligns the CFO's interests with shareholders and aids retention, it does not present new information that would fundamentally alter the company's valuation or strategic direction. The underlying context of a terminated merger might warrant further investigation into the company's strategic path, but this specific filing itself is not a catalyst for a strong buy or sell decision. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while monitoring future developments.

Keywords

Cross Country Healthcare, CCRN, William J. Burns, CFO, Restricted Stock Award, RSA, Equity Grant, Executive Compensation, SEC Form 4, Insider Transaction, Merger Termination, Aya Healthcare